These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 35879201)

  • 1. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
    Davenport C; Rai N; Sharma P; Deeks JJ; Berhane S; Mallett S; Saha P; Champaneria R; Bayliss SE; Snell KI; Sundar S
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011964. PubMed ID: 35879201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis.
    Davenport CF; Rai N; Sharma P; Deeks J; Berhane S; Mallett S; Saha P; Solanki R; Bayliss S; Snell K; Sundar S
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
    Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
    Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
    Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
    Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Lang S; Grimm S; Deshpande S; de Kock S; Armstrong N; Joore M; Kleijnen J
    Health Technol Assess; 2018 Aug; 22(44):1-264. PubMed ID: 30165935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
    Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
    Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass.
    Al Musalhi K; Al Kindi M; Al Aisary F; Ramadhan F; Al Rawahi T; Al Hatali K; Mula-Abed WA
    Oman Med J; 2016 Sep; 31(5):336-44. PubMed ID: 27602187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
    Yanaranop M; Anakrat V; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
    Gynecol Obstet Invest; 2017; 82(1):47-53. PubMed ID: 27197526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.
    Manzotti C; Casazza G; Stimac T; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012546. PubMed ID: 31283001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teledermatology for diagnosing skin cancer in adults.
    Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal.
    Melo Â; Veríssimo R; Farinha M; Martins NN; Martins FN
    J Obstet Gynaecol; 2018 Nov; 38(8):1140-1145. PubMed ID: 29884096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.
    Dinnes J; Deeks JJ; Chuchu N; Ferrante di Ruffano L; Matin RN; Thomson DR; Wong KY; Aldridge RB; Abbott R; Fawzy M; Bayliss SE; Grainge MJ; Takwoingi Y; Davenport C; Godfrey K; Walter FM; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011902. PubMed ID: 30521682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults.
    Ferrante di Ruffano L; Takwoingi Y; Dinnes J; Chuchu N; Bayliss SE; Davenport C; Matin RN; Godfrey K; O'Sullivan C; Gulati A; Chan SA; Durack A; O'Connell S; Gardiner MD; Bamber J; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013186. PubMed ID: 30521691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre external validation of IOTA prediction models and RMI by operators with varied training.
    Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T
    Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
    Lycke M; Kristjansdottir B; Sundfeldt K
    Gynecol Oncol; 2018 Oct; 151(1):159-165. PubMed ID: 30149898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.